Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03548012
Other study ID # R173-A11289-17-S51
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 15, 2018
Est. completion date October 15, 2021

Study information

Verified date August 2021
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the project is to evaluate the use of the caregiver-led 'CSNAT intervention' to identify, prioritize and address support needs among caregivers of cancer patients who are starting in basic palliative care at home in Denmark


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 135
Est. completion date October 15, 2021
Est. primary completion date October 15, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The patient should have advanced cancer - The caregiver and patient should be able to read and understand Danish - The caregiver and patient should give written informed consent - The patient should be newly referred to basic palliative care (BPC) by home nurses in the municipality. Exclusion Criteria: - The caregiver is viewed by the practitioners as being too distressed to be asked about participation - The caregiver has a known cognitive impairment precluding participation (based on the practitioners' clinical judgement)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
The Carer Support Needs Assessment Tool (CSNAT) intervention
The CSNAT intervention is a caregiver-led approach where the caregiver first identifies his/her needs of support in the CSNAT, which consists of 14 support domains. Then the practitioner facilitates the intervention where the caregiver prioritizes which domains to discuss. In the conversation, the caregiver's domain priorities and subsequently identified support needs are discussed with the practitioner to agree on actions/solutions and a shared action plan. The intervention will be offered each caregiver twice: the first time between 0 and 13 days after enrollment, and the second time between 15 and 27 days after enrollment.

Locations

Country Name City State
Denmark Aalborg Home Nursing Aalborg
Denmark Esbjerg Home Nursing Esbjerg
Denmark Gentofte Home Nursing Gentofte
Denmark Gladsaxe Home Nursing Gladsaxe
Denmark Haderslev Home Nursing Haderslev
Denmark Hjørring Home Nursing Hjørring
Denmark Holbæk Home Nursing Holbæk
Denmark Næstved Home Nursing Næstved
Denmark Odense Home Nursing Odense
Denmark Silkeborg Home Nursing Silkeborg

Sponsors (12)

Lead Sponsor Collaborator
Bispebjerg Hospital Danish Cancer Society, Home care nursing in the Municipality of Aalborg, Home care nursing in the Municipality of Esbjerg, Home care nursing in the Municipality of Gentofte, Home care nursing in the Municipality of Gladsaxe, Home care nursing in the Municipality of Haderslev, Home care nursing in the Municipality of Hjørring, Home care nursing in the Municipality of Holbæk, Home care nursing in the Municipality of Næstved, Home care nursing in the Municipality of Odense, Home care nursing in the Municipality of Silkeborg

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Caregiver strain Caregiver strain is measured by the subscale 'Caregiver Strain' in the Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC). Subscale score range: 1-5. A higher score represents a worse outcome, i.e. more caregiver strain. Change from baseline (enrollment) to day 14
Secondary Caregiver strain Caregiver strain is measured by the subscale 'Caregiver Strain' in the Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC). Subscale score range: 1-5. A higher score represents a worse outcome, i.e. more caregiver strain. Change from baseline (enrollment) to day 28
Secondary Positive caregiving appraisals Positive caregiving appraisals is measured by the subscale 'Positive caregiving appraisals' in the Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC). Subscale score range: 1-5. A higher score represents a better outcome, i.e. more positive caregiving appraisals. Change from baseline (enrollment) to day 14
Secondary Positive caregiving appraisals Positive caregiving appraisals is measured by the subscale 'Positive caregiving appraisals' in the Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC). Subscale score range: 1-5. A higher score represents a better outcome, i.e. more positive caregiving appraisals. Change from baseline (enrollment) to day 28
Secondary Caregiver distress Caregiver distress is measured by the subscale 'Caregiver distress' in the Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC). Subscale score range: 1-5. A higher score represents a worse outcome, i.e. more caregiver distress Change from baseline (enrollment) to day 14
Secondary Caregiver distress Caregiver distress is measured by the subscale 'Caregiver distress' in the Family Appraisal of Caregiving Questionnaire for Palliative Care (FACQ-PC). Subscale score range: 1-5. A higher score represents a worse outcome, i.e. more caregiver distress Change from baseline (enrollment) to day 28
Secondary Satisfaction with attention from health care professionals Measured by the subscale 'Lack of attention from health care professionals on the caregivers' wellbeing' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more lack of attention from health care professionals Change from baseline (enrollment) to day 14
Secondary Satisfaction with attention from health care professionals Measured by the subscale 'Lack of attention from health care professionals on the caregivers' wellbeing' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more lack of attention from health care professionals Change from baseline (enrollment) to day 28
Secondary Satisfaction with communication with health care professionals Measured by the subscale 'Problems with the quality of information from and communication with health care professionals' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more problems with the quality of information from and communication with health care professionals Change from baseline (enrollment) to day 14
Secondary Satisfaction with communication with health care professionals Measured by the subscale 'Problems with the quality of information from and communication with health care professionals' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more problems with the quality of information from and communication with health care professionals Change from baseline (enrollment) to day 28
Secondary Satisfaction with information from health care professionals Measured with selected items from the subscale 'Lack of information from health care professionals' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Item/subscale score range: 0-100. A higher score represents a worse outcome, i.e. more lack of information from health care professionals Change from baseline (enrollment) to day 14
Secondary Satisfaction with information from health care professionals Measured with selected items from the subscale 'Lack of information from health care professionals' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Item/subscale score range: 0-100. A higher score represents a worse outcome, i.e. more lack of information from health care professionals Change from baseline (enrollment) to day 28
Secondary Caregiving workload Measured with selected items from the subscale 'Caregiving workload' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Item/subscale score range: 0-100. A higher score represents a worse outcome, i.e. more caregiving workload Change from baseline (enrollment) to day 14
Secondary Caregiving workload Measured with selected items from the subscale 'Caregiving workload' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Item/subscale score range: 0-100. A higher score represents a worse outcome, i.e. more caregiving workload Change from baseline (enrollment) to day 28
Secondary Caregiver involvement Measured with item 12 in the Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Item score range: 0-100. A higher score represents a worse outcome, i.e. more caregiver dissatisfaction with involvement Change from baseline (enrollment) to day 14
Secondary Caregiver involvement Measured with item 12 in the Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Item score range: 0-100. A higher score represents a worse outcome, i.e. more caregiver dissatisfaction with involvement Change from baseline (enrollment) to day 28
Secondary Help from health care professionals Measured with two newly developed items which ask whether the health care professionals have talked with the caregiver about what burdens them, and whether the health care professionals have helped with these burdens. Item score range: 0-100. A higher score represents a worse outcome, i.e. less help from health care professionals Change from baseline (enrollment) to day 14
Secondary Help from health care professionals Measured with two newly developed items which ask whether the health care professionals have talked with the caregiver about what burdens them, and whether the health care professionals have helped with these burdens. Item score range: 0-100. A higher score represents a worse outcome, i.e. less help from health care professionals Change from baseline (enrollment) to day 28
Secondary Quality of life Measured by the two items assessing overall health and quality of life in the EORTC Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Item score range: 0-100. A higher score represents a better outcome, i.e. better quality of life Change from baseline (enrollment) to day 14
Secondary Quality of life Measured by the two items assessing overall health and quality of life in the EORTC Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Item score range: 0-100. A higher score represents a better outcome, i.e. better quality of life Change from baseline (enrollment) to day 28
Secondary Emotional functioning Measured by the four emotional functioning items in EORTC Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) supplemented with three selected items from the EORTC Computerized Adaptive Test (CAT) emotional functioning item bank. Item/subscale score range: 0-100. A higher score represents a better outcome, i.e. better emotional functioning Change from baseline (enrollment) to day 14
Secondary Emotional functioning Measured by the four emotional functioning items in EORTC Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) supplemented with three selected items from the EORTC Computerized Adaptive Test (CAT) emotional functioning item bank. Item/subscale score range: 0-100. A higher score represents a better outcome, i.e. better emotional functioning Change from baseline (enrollment) to day 28
Secondary Fatigue Measured by the three fatigue items in EORTC Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) supplemented with three selected items from the EORTC Computerized Adaptive Test (CAT) fatigue item bank. Item/subscale score range: 0-100. A higher score represents a worse outcome, i.e. more fatigue Change from baseline (enrollment) to day 14
Secondary Fatigue Measured by the three fatigue items in EORTC Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) supplemented with three selected items from the EORTC Computerized Adaptive Test (CAT) fatigue item bank. Item/subscale score range: 0-100. A higher score represents a worse outcome, i.e. more fatigue Change from baseline (enrollment) to day 28
Secondary Positive emotional functioning Measured by five positively formulated items concerning emotional functioning which were excluded from the EORTC Computerized Adaptive Test (CAT) emotional functioning bank during the development of the item bank. Item score range: 0-100. A higher score represents a better outcome, i.e. more positive emotional functioning Change from baseline (enrollment) to day 14
Secondary Positive emotional functioning Measured by five positively formulated items concerning emotional functioning which were excluded from the EORTC Computerized Adaptive Test (CAT) emotional functioning bank during the development of the item bank. Item score range: 0-100. A higher score represents a better outcome, i.e. more positive emotional functioning Change from baseline (enrollment) to day 28
Secondary Caregiver grief Measured by the Prolonged Grief Scale-13 (PG-13). Symptom subscale score range: 9-45. A higher score represents a worse outcome, i.e. higher level of prolonged grief symptoms Measured six months after the patient's death
Secondary Acute hospitalizations Number of acute patient hospitalizations Change from baseline (enrollment) to day 14
Secondary Acute hospitalizations Number of acute patient hospitalizations Change from baseline (enrollment) to day 28
Secondary Hospice referrals (for in-patient care) Number of patients referred to hospice in-patient care Change from baseline (enrollment) to day 14
Secondary Hospice referrals (for in-patient care) Number of patients referred to hospice in-patient care Change from baseline (enrollment) to day 28
Secondary Survival time Number of days the patient lives From enrollment to up to six months after the project recruitment period has closed
Secondary Place of death The place in which the patient dies From enrollment to up to six months after the project recruitment period has closed
See also
  Status Clinical Trial Phase
Completed NCT04673760 - The PROAKTIV Study N/A
Completed NCT03520023 - Critical Care and Palliative Care Medicine Together in the ICU N/A
Completed NCT01990742 - Improving Palliative Care Through Teamwork N/A
Not yet recruiting NCT05434208 - Effects of Nurse-led Telephone Based Service for Early Palliative Care (PALTEL) N/A
Not yet recruiting NCT03267706 - Introducing the Palliative Care Comprehensive Tool in Family Medicine N/A
Completed NCT02845817 - Requests for Euthanasia and Assisted Suicide N/A
Recruiting NCT02778347 - Development and Validation of a Comprehensive Standardised Clinical Assessment Tool for Patient Needs N/A
Completed NCT01933789 - Improving Communication About Serious Illness N/A
Completed NCT01934413 - Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study N/A
Recruiting NCT01170000 - Timely End-of-Life Communication to Parents of Children With Brain Tumors N/A
Recruiting NCT04052074 - Complementary Therapy in Home Palliative Care Patients and Their Caregivers N/A
Recruiting NCT05935540 - ACP-Family Programme for Palliative Care Patients and Their Family Member N/A
Active, not recruiting NCT02689375 - A Prospective, Open Label, Pilot Study of Patient OutcoMes Following Successful TriAl of High Frequency SpInal CorD Stimulation at 10kHz (HF10™) Leading to Permanent Implant Compared to Trial Failure and Standard CarE for the TreatmeNt of Persistent Low BACK Pain of Neuropathic Origin N/A
Recruiting NCT05520281 - Short-term Psychodynamic Psychotherapy in Serious Physical Illness N/A
Completed NCT06140004 - Home-Based Palliative Care Impact on Providers
Completed NCT04333719 - Prevalence of Deep Sedation in Terminal Palliative Phase
Recruiting NCT03286127 - Palliative Outcome Evaluation Muenster I
Completed NCT06211816 - Efficacy of End-of-life Communication Strategies on Nurses in the Intensive Care Unit N/A
Completed NCT04857060 - Palliative Care Educator N/A
Completed NCT04491110 - Intervention to Improve Quality of Sleep of Palliative Patient Carers in the Community: Clinical Trial N/A